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Abstract
Purpose To conduct a systematic review of the possibilities of artificial intelligence (AI) in neuroradiology by performing an
objective, systematic assessment of available applications. To analyse the potential impacts of AI applications on the work of
neuroradiologists.
Methods We identified AI applications offered on the market during the period 2017–2019. We systematically collected and
structured information in a relational database and coded for the characteristics of the applications, their functionalities for the
radiology workflow and their potential impacts in terms of ‘supporting’, ‘extending’ and ‘replacing’ radiology tasks.
Results We identified 37 AI applications in the domain of neuroradiology from 27 vendors, together offering 111 functionalities.
The majority of functionalities ‘support’ radiologists, especially for the detection and interpretation of image findings. The
second-largest group of functionalities ‘extends’ the possibilities of radiologists by providing quantitative information about
pathological findings. A small but noticeable portion of functionalities seek to ‘replace’ certain radiology tasks.
Conclusion Artificial intelligence in neuroradiology is not only in the stage of development and testing but also available for
clinical practice. The majority of functionalities support radiologists or extend their tasks. None of the applications can replace the
entire radiology profession, but a few applications can do so for a limited set of tasks. Scientific validation of the AI products is
more limited than the regulatory approval.
Keywords Artificial intelligence (AI) . Machine learning . Organizational innovation . Neurology/diagnostic imaging .
Radiology . Technography
Introduction
Currently, artificial intelligence (AI) is a significant yet
emerging technological innovation in healthcare. AI
represents technologies that involve developing machines
that can perform tasks that are characteristic of human
intelligence [1]. Neuroradiology is one of the leading
subspecialties in radiology in terms of the diversity and
number of AI applications [2, 3]. Examples include the
automated identification of stroke [4] and the automated
volumetric measurement of multiple sclerosis lesions by
artificial neural networks [5]. In this paper, we systemat-
ically assess the potential impacts of AI in neuroradiol-
ogy and offer an overview of the state-of-the-art applica-
tions on the market.
Disruptive innovation has an impact on the tasks that
professionals perform [6]. The term disruptive refers to
a fundamental change in the way the work is tradition-
ally conducted. In our study, we aim to assess how
disruptive AI can be for the radiologist’s job: are radi-
ologists replaced by AI, are the possibilities of the ra-
diologist extended by AI or are the radiologists support-
ed by AI?
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Currently, AI, especially deep learning, is receiving much
attention as a disruptive innovation in medicine, especially
radiology. Based on the number of articles, we may wonder
to what extent this is another case of temporary hype or if there
are substantial clinical applications beyond the hype [7]. In
addition to the high expectations regarding the impacts of AI
on knowledge work [8], the fear of change and losing jobs is
also salient [9].
Despite all the attention paid to AI in radiology, publica-
tions generally provide information on the technical aspects of
AI or about its application in a specific domain to showcase
examples of its potential impact on the job of the radiologist
[2, 9, 10]. To what degree AI can support, extend or replace
what radiologists used to do is not systematically analysed,
especially through a comprehensive overview of the existing
AI applications. It is essential to know the type of impacts that
AI can bring about to better formulate reaction strategies for
working with AI [11].
Despite its importance, systematic evaluations of the
functionalities of AI applications that are offered to the
market are scarce [10]. Thorough examination of the
existing AI applications and their functionalities for the
radiology workflow help us understand if and how AI
will influence the daily practices of neuroradiologists.
The assessment of the usage of technology and the im-
pact of technology is a known scientific approach called
technography [12].
Research onAI should include not only the development of
algorithms but also the broader impact of AI, such as the
impact on the daily work of the radiologist [13]. New technol-
ogies require new evaluation approaches [14], and a system-
atic technographic review could provide an objective counter-
balance to personal, subjective opinions on the value of AI in
clinical practice.
A technography follows the same approach as a systematic
literature review. Instead of reviewing the publications, it re-
views instances of ‘technological developments’ in a domain.
Each record is evaluated in a predefined systematic way to
provide an objective assessment of the current status of the
technological developments, their characteristics, and their fo-
cuses. Technography enables us to map out technological de-
velopments and thereby identify gaps and suggest opportuni-
ties for future developments.
The radiology workflow contains many steps, and it is
unknown whether current AI applications have an impact.
To assess the impact of AI on the radiology profession, we
need to scrutinize the functionalities of AI applications and
map them to the radiology workflow. A clear overview of
AI developments and detailed analysis of their functionalities
help radiology departments and radiologists make more in-
formed decisions and prepare for the future. It also helps re-
searchers and application developers identify areas that are
eligible for future development.
Purpose
1. Obtain a comprehensive, systematic overview of AI func-
tionalities for neuroradiology by performing an objective,
systematic assessment of available AI applications.




In this mixed-method study, the intersection of the prom-
ises of AI and the workflow of neuroradiology is ex-
plored. The factual information about AI companies and
applications is combined with an assessment of workflow
and their impacts based on qualitative codebooks. Our
approach has some similarities with a PRISMA system-
atic literature review, but also some differences. The sim-
ilarities are systematic storage of data, systematic analy-
sis with a predefined codebook with definitions and
clearly described reproducible methodology. The differ-
ences are that our sampling is not performed with a que-
ry in a literature database, the data is not extracted from
scientific publications but from vendors’ websites and
that the research question is not entirely predefined, but
is exploratory, which required the collection of additional
data during the research process (information about plat-
forms, funding information, scientific validation
information).
Data collection and coding
Data collection, coding and analysis were performed, as indi-
cated in Fig. 1. The conferences used as a source were selected
based on their comprehensiveness or the subspecialties neu-
roradiology and imaging informatics. There was no restriction
on the location of the companies. We did not consider non-
commercial applications that also provide solutions, which are
commonly used in research.
A radiologist with 10+ years of experience in neuroradiol-
ogy (AO) performed the coding of the collected data by using
codebooks to examine which tasks of radiology [15, 16] are
targeted by an application and what kind of impacts it can
have on these tasks (i.e. ‘supporting’, ‘extending’, ‘replacing’;
Table 1). These tasks range from providing information to
patients and referring physicians to the interpretation of an
examination and the communication of results in a report or
multidisciplinary team meeting [17].
The reference point was the technological descriptions
of the application and the use cases that are presented.
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Table 1 Codebook for
classification of impact Definition Inclusion/exclusion criteria and examples
Supporting
The functionality helps some inefficient task but does
not fundamentally change the primary/current
workflow, the interference of human actors is still
required, and the process of task/workflow is still
the same.
(1) does not change the entire task
(2) make the process more efficient compared to prior
activities
(3) still requires human involvement
(4) the system only helps humans to do their job
Example: visualization the images and information
Replacing
The functionality performs a certain task that was
previously conducted by a human actor; thus, now
the human actor is (almost) not needed for
conducting this specific task.
(1) changes the particular fundamental task
(2) does not require human involvement
(3) technology replacing the current human action
(4) the task was previously conducted by human
actors
Example: autonomous reading and reporting
radiology cases
Extending
Technology offers a functionality that was not
previously performed by human actors or the
previous systems, and now, with this new
functionality, a new task is added to the work and
may require the improvement of human
capabilities.
(1) creates a new task in the workflow
(2) does require human involvement but solves the
problem through an algorithm
(3) improves/extends human skills and knowledge
(4) the tasks were previously non-existent
Example: provide diagnostic information that was not
available before, such as a heatmap of suspicious
areas.
Fig. 1 Research flow chart.
RSNA =Radiological Society of
North America. ECR = European
Congress of Radiology. ESR




SIIM = Society for Imaging
Informatics in Medicine.
Neuroradiology is defined as
applications related to the brain or
spinal cord as anatomical areas or
related to specific diseases of the
brain or spinal cord. (*) company
websites, LinkedIn.com,
Crunchbase.com, and the FDA
website
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For some functionalities, more than one of these impacts
were selected (e.g. both supporting and replacing) when
the impact could be multiple (e.g. depending on how the
application is implemented in practice). The AI charac-
teristics were scored based on a hierarchical classification
[2], where deep learning is a subcategory of machine
learning and machine learning is a subcategory of AI.
If the vendor website did not offer a specification (ma-
chine learning or deep learning), we categorized the ap-
plication under the broad category of ‘artificial
intelligence’.
Applications without information on FDA approval were
additionally checked at the public FDA website. For CE ap-
proval, no additional check was performed because there is no
centralized public database.
Database architecture
The primary data fields are ‘companies’, ‘platforms’, ‘appli-
cations’ and assessments of these applications. A relational
database was designed to store and classify the data
(Appendix Fig. 7 and Table 7). The data structure allowed
one-to-many relationships: one company can have several ap-
plications, and one application can have several functionalities
concerning various radiology tasks. Each application can have
several types of approval certificates (e.g. FDA, CE marked),
be used for several modalities (e.g. CT and MRI) and be re-
lated to different pathologies (e.g. dementia and stroke).
Among the technological characteristics of the applications,
information about PACS integration and whether the applica-
tion works in the cloud or on-premise is collected.
In a separate list, we assessed the characteristics of the
‘platforms’ that we found during the search and analysis of
AI applications. A platform in this context is the application
through which the AI application is distributed and accessed
(Table 2). Only platforms that are used for AI applications in
neuroradiology are included. How an application addresses a
platform is a distinctive feature and provides information on
the usability of the application.
Results
Overview of companies and applications
We identified 37 applications of 27 companies from three
continents. Most of the companies active in offering AI solu-
tions are relatively small and young (Fig. 2). For half of the
companies, we found information about their funding, which
shows an uneven distribution of the amount of funding be-
tween the continents (Fig. 3). The majority of companies
(74%) have a single product in this field (Table 3).
Technological characteristics of platforms
and applications
Platforms
We identified that applications could run on three types of
platforms (Table 2). Some platforms are intended to be used
with specific neuroradiology applications. Other platforms
can be used to develop applications. The third group of plat-
forms (‘marketplace’) provides many applications for many
subspecialties within radiology (Table 4). Users can access the
applications by using the platform.
Applications
We categorized 12 (32%) applications under the broad cate-
gory of AI, since they did not specify which type of algorithm
they use. Machine learning (ML) was mentioned for eight
(22%) and deep learning (DL) or convolutional neural net-
works for 17 (46%) applications. No specific information
about technical details of algorithms or details about the train-
ing and validation data is available in the general information
of the application websites.
Of all applications, 23 (62%) have seamless PACS integra-
tion, and 17 (46%) make use of cloud-based computing
(Table 5).
Application regulatory approval
Thirteen (35%) applications have both FDA and CE approval,
and 25 (68%) have at least one type of approval (Fig. 5). There
is a regional variation in the percentage of applications with
one or more approvals: Asia, 10 (91%); Europe, 8 (73%); and
North America, 7 (64%). From the product of companies
founded before 2014, 14 (88%) have one or more applications
with one or more approval, compared with 11 (52%) of the
applications that are offered by the companies founded in or
after 2014.
Modality and pathology type
All applications analyse images of one or more of the follow-
ing imaging modalities: MRI (19; 51%), CT (19; 51%), MR
perfusion (2; 5%), CT perfusion (3; 8%), CT angiography (5;
14%) and MR angiography (1; 3%).
Most applications are designed to be used for one patholo-
gy. The common pathologies are as follows: ischaemic stroke
(13; 35%), intracranial haemorrhage (10; 27%) and mild cog-
nitive impairment and dementia, including subtypes such as
Alzheimer’s disease (7; 19%), multiple sclerosis (4; 11%),
tumour (4; 11%), traumatic brain injury (3; 8%), Parkinson’s
disease (2; 5%) and intracranial aneurysm (1; 3%).
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In all three groups of regulatory approval (FDA, CE, oth-
er), the categories ischaemic stroke, intracranial haemorrhage
and dementia are more frequent than the other categories are.
Application functionalities and radiology workflow
Table 6 shows an overview of the functionalities of all appli-
cations, each accompanied by an explanation and an example.
Figure 6 demonstrates the distribution of the functionalities
over the workflow steps. One application can be mapped to
one or more workflow steps.
Impact on radiology work
Most functionalities of applications (39; 54%) are designed to
‘support’ radiologists in performing their current tasks
(Fig. 4). Some other functionalities of applications ‘extend’
the work of radiologists by providing quantitative information
that would not be possible before the introduction of these
applications (23; 32%). Only a few functionalities of applica-
tions (10; 14%) offer functionalities that take over certain
tasks. A common example of replacing functionality is the
preparation of a report. Both in the approved and not-yet-
approved applications, the most frequent category is
‘supporting’, followed by ‘extending’ and ‘replacing’.
To illustrate the different categories, we provide several ex-
amples here. An application in the ‘supporting’ category is e-
Aspects (Brainomix). This application automatically derives the
aspect score for patients suffering from ischaemic stroke.
Icobrain dm (Icometrix) extends the possibilities of the
radiologist by providing volumetric information about the
brain and comparing this information with a normative
database.
An example of an application that can replace the radiolo-
gist for a task is VIZ LVO (Viz.ai). The application alerts the
on-call stroke team in case of large vessel occlusion.
An application sometimes offers functionalities related to all
three categories. For instance, the AI reader (Qmenta) supports
the radiologist in making a diagnosis, extends radiology work by
providing quantitative information and can replace the radiologist
in drafting an automated report for the referring physician.
Scientific validation
Half of the applications offer some kind of scientific proof to
show their validity. For five (14%) applications, the websites
provide information about conference abstracts or publica-
tions, and for 13 (36%), there is both information at the
websites and one or more peer-reviewed publications at
PubMed. For 19 (51%) applications, there is no information
about scientific validation.
Fig. 3 Geographical distribution of acquired funding of 13 of the 27
companies summed and averaged. The amounts in the national
currencies have been converted to Euro. The average funding is
calculated for all companies in each continent
Fig. 2 The founding year of the 27 companies and the distribution of the
companies among the size categories, according to the number of
employees
Table 2 Platform categories
Category Explanation
Small/“Umbrella” Applications of one vendor accessible through one umbrella product.
Intermediate/“Storage box” Platform for in-house development of AI algorithms




This work describes a systematic technographic review of
the functionalities and potential impact of AI applications
and the characteristics of the vendors. Some vendors have
more than one application, each for a specific task, while
others have one application that can perform several tasks.
Our approach addressed this by using a relational












MaxQ AI’s diagnostic suite is being deployed
directly onto both CT and PACS systems.
Both Yes No Yes 3 (8%) 3
e-Stroke Suite
e-Stroke Suite combines e-Aspects, e-CTA, and
e-Mismatch.
Cloud-based Yes No Yes 2 (5%) 3
Intermediate/“Storage box”
CuraCloud
AI Development Services supply medical
imaging AI expertise and technical
capabilities to healthcare organizations to
create their own quality and productivity
innovations using computer vision, machine
learning, natural language processing, and
other advanced informatics.
Cloud-based Yes Yes No 1 (3%) 9
Incepto
Incepto provides a collaborative environment to
co-create, develop and distribute
revolutionary applications for the diagnosis
and treatment of diseases.
Cloud-based No Yes No 1 (3%) 8
Large/“Marketplace”
Blackford
Blackford provides a single platform to access
and manage a curated marketplace of
regulatory approved medical image analysis
applications and AI algorithms that add
clinical value.
Cloud-based Yes Yes No 4 (11%) 13
EnvoyAI
EnvoyAI provides a developer platform,
integrations and an API interface for
algorithm developers, technology partners,
and end users.
Both Yes Yes No 11 (30%) 57
Nuance AI Marketplace
Workflow-integrated market for diagnostic
imaging AI algorithms.
Cloud-based No Yes No 9 (24%) 25
a In brackets are the number of applications that indicate working with this particular platform. One application can be related to 1 or more platforms. For
19 (51%) applications, it is unknown whether they can work with a platform
b Total number of applications/tools available at this platform for both neuroradiology and other subspecialties
Table 3 Number of applications
per company Number of applications per company Number of companies Total number of applications
3 3 (11%) 9 (24%)
2 4 (15%) 8 (22%)
1 20 (74%) 20 (54%)
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database [18] in which many functionalities or workflow
items can be assigned to one application. This flexibility
allowed us to conduct analysis not only at the application
level but also at the functionality level.
Companies and applications
The relatively high number of applications and the fact that
most companies are young confirm the recent attention in the
literature to AI in neuroradiology. Because of the limited in-
formation about funding, we cannot draw definite conclu-
sions, but it is interesting to see that the companies leading
the funding list are in China.
Table 6 Functionalities with







Measures the characteristics of pathologic findings.
Example: InferRead CT Stroke detects haemorrhagic stroke,
marks the location and assesses the volume to assist
radiologists in their diagnosis and determining the prognosis
of a patient






Detects and highlights abnormal findings visually.
Example: VIZ LVO uses artificial intelligence to automatically
identify suspected large vessel occlusion strokes on CT
angiogram imaging. Change Detector compares serial
magnetic resonance imaging studies and presents changes in







Interprets imaging findings and provides a diagnosis or a
standardized classification.
Examples: Rapid Aspect automatically generates a standardized
score, based on clinically validated machine learning
algorithms, that enables communication about the extent of a
patient’s ischaemic changes. Deepstroke provides ASPECT






Organizes the diagnostic findings in a report.
Example: Atroscan provides reports with quantitative
information through comparative analysis of the same age
group.






Compares the quantitative information about anatomy or
pathology with normal findings of a particular group.
Example:Quantib ND provides insight into the possible presence
of atrophy related to Alzheimer’s disease or other types of
dementia, thus supporting more accurate diagnosis, and makes







Facilitates the efficacy of the diagnostic process.
Example: RadReport states that radiologists work faster and
better with diagnostic decision support and standardized
reports. qER includes a triage aid to prioritize and notify




Segments the images in normal anatomical areas.
Example: Quibim Precision is to designed to automatically
calculate the volume of brain tissues and their regions and the








Modality integrationa 3 (4%)
Unknown integration 7 (19%)
Cloud or on-premise
Cloud-based computation 17 (46%)
On-premise computationb 5 (14%)
Location unknown 17 (46%)
a Three applications have modality integra-
tion, in addition to seamless integration
b One application is categorized as both




For the majority of the applications, no information was avail-
able regarding the platform on which the applications run;
thus, radiology departments will benefit from more detailed
information from the vendors before they determine the appli-
cation that best fits their needs.
For the majority of applications (68%), the type of
AI (machine learning or deep learning) was provided.
Some companies provide this information in detail,
while others do not or provide it in a superficial man-
ner. For radiologists, it is crucial to know the strength
and weaknesses of the technology that they use to im-
prove quality, ensure safety and understand artefacts
[19, 20]. Additionally, radiologists need to understand
technical information about the applications [21] to
recognize the strengths and pitfalls of AI applications
[22]. Information about the training data of algorithms
and whether external validation was performed helps
radiologists assess the credibility and applicability of
an AI application in their hospital [23]. This type of
data was limited. Close collaboration between radiolo-
gists and vendors is needed to ensure the true clinical
utility of algorithms [24].
In addition to the algorithmic details of an AI appli-
cation, the way the application can be integrated into
the work environment has an impact on the job of the
radiologist. Usability is essential to ensure that radiolo-
gists use the application in their daily work [25, 26].
The seamless PACS integration of many of the investi-
gated AI applications facilitates radiologists’ efforts in
using these applications. Even though our data do not
show more detailed information about PACS integration,
this finding indicates the awareness of vendors that in-
tegration in the daily workflow is essential for the adap-
tion of the applications by radiologists.
Regulatory approval
The fairly high percentage of approved applications dem-
onstrates that AI in neuroradiology is not only in the
state of developing and testing but also available for
the radiologist in daily practice. Approval can be a
starting point for evaluating the benefits of AI applica-
tion for the health outcomes of patients, which requires
higher levels of evidence than what is often needed for
regulatory approval [27].
Modalities and pathology
Neuroradiology heavily relies on MRI and CT, so it is not
surprising that most applications are made to be used with
MRI or CT data. The types of pathology that can be handled
by the applications in our database reflect the frequently en-
countered diseases in neuroimaging. However, other major
categories of disease for which neurologists and other special-
ists request imaging are missing, for example radiculopathy
and epilepsy. In defining clinical challenges such as these,
radiologists can contribute to translational research in artificial
intelligence [28].
Functionalities and workflow
The most numerous functionalities are directly related to the
core business of a radiologist: finding and interpreting abnor-
malities and making the correct diagnosis. This fact indicates
that AI companies develop products that are genuinely rele-
vant to radiologists.
Fig. 5 Approval of applications. Each circle represents several
applications that are approved by a particular organization. The FDA is
the Food and Drug Administration of the United States. CE means CE-
marked. CEmarking is a certificationmark that indicates conformity with
health, safety and environmental protection standards for applications
sold within the European Economic Area (EEA). Numbers in the
intersecting parts fall under two or more categories. The ‘other’
category represents the approval bodies of Australia, Canada, Korea,
Singapore and Vietnam
Fig. 4 Sankey flow diagram. From left to right, the columns of items
represent the companies, the functionalities and the impact. The size of
each item corresponds to the relative value within the category. For
example, the most frequent affordance is ‘quantification (pathology)’,
and the most frequent impact is ‘supporting’
R
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The items designated to the category ‘quality assur-
ance’ are mainly designed to improve the workflow. No
applications were found that perform a more direct qual-
ity assurance task, such as assessment of the complete-
ness or quality of reports.
There is a shortage of applications and functionalities re-
lated to the early stages of the workflow (e.g. scheduling,
acquisition and pre-processing) and the final stages (e.g.
reporting and communication). This indicates the opportuni-
ties for companies and radiologists to develop applications in
areas beyond image interpretation [29, 30].
Impact on the job of a radiologist
Scientific journals dedicate papers and editorials to the
emerging development of AI, wondering “Will Artificial
Intelligence Replace Radiologists?” [31]. In general, AI
will impact parts of many jobs, but other tasks within
these same jobs will not change [32]. This is confirmed
by our results. Currently, AI applications do not offer
functionalities that can replace radiologists. The few ap-
plications that have the potential to replace the radiolo-
gist only can do that for a limited set of tasks, such as
pre-drafting reports and analysing a stroke patient. In
fact, the applications available on the market are still
narrow-AI applications, meaning that they focus on
one small task. This term can be applied to the AI tools
that support or replace the radiologist for a single task,
while the radiologist is needed to accomplish a se-
quence of other tasks. These applications do not check
for other related or unrelated findings; therefore, the
radiologist still has a task.
This fact does not mean that AI has no impact on the radi-
ologist. Many applications are available, which can support
radiologists, especially for the ‘detection’ and ‘interpretation’
of the clinical insights, the two primary responsibilities of a
radiologist. Many applications also extend the work of radiol-
ogists. Quantitative information and biomarkers will enhance
the content of the radiology reports of radiologists who choose
to use these applications [33].
Scientific validation
Companies are struggling with both scientific and regu-
latory validations of their products, though we see that
the attempts to have sound scientific validation of the
AI products are more limited than the regulatory ap-
proval. For only a minority of applications, peer-
reviewed publications are available. This indicates that
regulatory approval is not the same as clinical validation
and confirms the remarks that most current applications
are not yet ready to accept clinical deployment [34, 35].
The impact on patient outcome has yet to be assessed
for almost all applications.
Reviewing new developments and providing an over-
view of the available applications is a well-established
research approach. For example, Landau et al. provided
an overview of AI in cytopathology and described both
the literature and commercial landscape in a comprehen-
sive review [36], Chen et al. described the current status
of AI in urology [37] and Murray et al. performed a sys-
tematic literature review on AI applications in neuroradi-
ology [38]. We found no other systematic technographic
reviews similar to our study.
Fig. 6 Workflow. The
functionalities of each application
are mapped to the items of the
workflow of a radiologist, as
described in the codebook in the
methods section. Applications
that detect and segment particular
pathologic conditions are
categorized under ‘detection’ and
are not double-categorized under
‘segmentation (pathology)’.
Applications that measure, for
example, brain volume in the
context of, for example, dementia,
are categorized under ‘quantifica-





The applications that are designed for diseases such as
stroke or dementia are specific to the neuroradiology
subspecialty. These tools are not directly applicable to
other subspecialties. However, the underlying concepts
of the applications we investigated are generalizable to
other types of pathology in neuroradiology or other sub-
specialties within radiology. These general concepts are
as follows:
– the prioritization of studies in the PACS worklist, based
on the presence of pathology
– the optimization of the workflow
– the quantification of anatomical structures and compari-
son with an age-based control group and the derivation of
biomarkers
– the automated detection and segmentation of pathology
– the automated classification for pathology based on
guidelines and specific criteria
This list indicates that radiology will not be the same in the
near future. Substantial investments in AI will boost research
and development in this domain [39].
Limitations
There is wide variation in the quality and completeness
of the information on the websites of the vendors. Our
results represent all available material that we thorough-
ly assessed. The characteristics of AI applications that
are not publicly available were beyond the scope of our
study, including applications that are commonly used in
research institutions.
We included only applications that mention “neurora-
diology” and “artificial intelligence” (or related words).
However, some applications offer advanced AI tools for
radiology that are also applicable in neuroradiology.
Applications that use automated processing but that do
not explicitly use AI were not included. Our results,
therefore, might underestimate the applications that have
an impact on the job of radiologists working in
neuroradiology.
We included applications from exhibitors of several
large radiology congresses in Europe and North
America. Although several companies from Asia were
present in our database, our results might be biased to-
wards Europe and North America. Especially because of
the high amount of funding acquired by some Asian
companies, a significant contribution to future AI devel-
opments from this continent can be expected.
Another limitation is that we did not have interrogated the
content of the scientific validation material. We only scored
the presence or absence of this.
Future research
As mentioned, AI is developing at a high pace.
Repeating our study over time helps us keep track of
these developments and develop a more accurate over-
view of their potential impacts on radiology work and
the radiology profession. This change over time will
also provide valuable information about the develop-
ment of this market. After-implementation feedback is
also very important to determine how an application is
actually used in terms of support, extension and
replacement.
Conclusion
Artificial intelligence in neuroradiology is not only in the
stage of development and testing but also available for clinical
practice. Many companies active in this area are young, am-
bitious and have acquired large amounts of funding. The ap-
plications developed are highly relevant for neuroradiology to
support the radiologist and to extend the possibilities of the
radiologist to add value to patient care. The main functional-
ities that support radiologists are the detection and interpreta-
tion of abnormal image findings. The primary functionality
that extends the possibilities of radiologists is the provision
of quantitative information. In the category ‘replacing’, some
applications are available that make radiology reports in spe-
cific domains. Scientific validation of the AI products is more
limited than the regulatory approval.
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Fig. 7 Database structure. For
data storage, a relational database
was developed in Microsoft
Access. For analysis, information
from different tables can be
combined in queries and exported
for visualization
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